Significant advancement achieved with ARDS-003 sterile injectable nano-emulsion finished drug product A new anti-inflammatory drug candidate OTTAWA, ON / ACCESSWIRE / August 18, 2020 / Tetra Bio-Pharma...
MONTREAL, QC / ACCESSWIRE / August 17, 2020 / Mondias Natural Products Inc. (TSXV:NHP) (the "Company" or "Mondias") specializing in evidence-based natural products for the healthcare and bio-agriculture...
Please disregard original release sent out and replace with the following. Tetra is accelerating its European activities Tetra's European project receives the approval and support from Malta Enterprise...
Tetra is accelerating its European activities Tetra's European project receives the approval and support from Malta Enterprise OTTAWA, ON / ACCESSWIRE / August 6, 2020 / Tetra Bio-Pharma Inc. ("Tetra"...
LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3rd - 6th, 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting...
- Resumption of its PLENITUDE© clinical trial on-time; - CAUMZ™ manufacturing set to begin in USA to allow start of clinical trials; - QIXLEEF™ metabolite mapping study to be complete in Q3 2020...
OTTAWA, CANADA / ACCESSWIRE / July 27, 2020 /Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is providing its...
FDA stated that the nonclinical program was appropriate to support initiating studies in COVID-19 patients
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
OTTAWA / ACCESSWIRE / July 9, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce...